News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Alnylam Pharmaceuticals
NEWS
JOBS
IN THE PRESS
NEWS
Policy
Sparring Over Trade Secrets, Dicerna Brings New Antitrust Suit Against Alnylam
August 11, 2017
·
1 min read
Drug Development
Could Alnylam Have An Edge On This Smaller Biotech In Rare Disease?
July 11, 2017
·
1 min read
Drug Development
Why All Eyes Will be on Alnylam and Any Updates of Its APOLLO Phase III Trial This Friday
May 11, 2017
·
2 min read
Genetown
Alnylam’s Patisiran, Chronicle Of A Death Foretold
April 11, 2017
·
1 min read
Business
Filings Reveal Alnylam CEO’s Pay Dropped Almost 80% in 2016
March 21, 2017
·
2 min read
Drug Development
Alnylam Execs Open Up About Patient Deaths in Abandoned Drug Trial
November 4, 2016
·
2 min read
Drug Development
The Ripple Effect of Alnylam’s Blow-up Yesterday
October 7, 2016
·
3 min read
Drug Development
Alnylam Stock Craters After Deaths Cause Clinical Trial to End
October 5, 2016
·
3 min read
4 Things To Learn From Medicine Development, Says Alnylam CEO
October 3, 2016
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
PeptiDream and Alnylam Announce Achievement of Key Milestone in siRNA Conjugate Discovery Collaboration Demonstrating Peptide-Ligand Mediated Targeted siRNA Delivery to Specific Extrahepatic Tissues
December 18, 2025
·
2 min read
Press Releases
Alnylam to Invest $250 Million to Add Enzymatic Ligation Platform to U.S. Manufacturing Facility to Meet Growing Global Demand for RNAi Therapeutics
December 18, 2025
·
10 min read
Press Releases
Alnylam Announces Health Canada Approval of AMVUTTRA® (vutrisiran), the First and Only RNAi Therapeutic for the Treatment of Cardiomyopathy in Adult Patients with ATTR Amyloidosis
December 17, 2025
·
10 min read
Press Releases
Alnylam Announces Partial Repurchase of 1.00% Convertible Senior Notes Due 2027
December 12, 2025
·
4 min read
Press Releases
Alnylam Pharmaceuticals Announces Changes to Board of Directors
December 3, 2025
·
7 min read
Press Releases
Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple Myeloma, Lymphoma and Paroxysmal Nocturnal Hemoglobinuria Programs
November 14, 2025
·
24 min read
Press Releases
New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM
November 10, 2025
·
15 min read
Press Releases
Alnylam to Webcast Presentations at Upcoming November 2025 Investor Conferences
November 5, 2025
·
1 min read
Press Releases
Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress
October 31, 2025
·
19 min read
Press Releases
Alnylam to Webcast Conference Call Discussing Third Quarter 2025 Financial Results
October 17, 2025
·
1 min read
